NYSE:ENOVMedical Equipment
How Investors May Respond To Enovis (ENOV) Raising Guidance Despite a Major Goodwill Impairment
Enovis Corporation recently reported third-quarter 2025 earnings, with sales rising to US$548.91 million and an operationally strong performance offset by a very large goodwill impairment of US$548.44 million.
The company raised full-year guidance for adjusted EPS and EBITDA, underscoring increased confidence in its core business segments despite the significant non-cash charge and the sale of its Dr. Comfort business unit.
We'll explore how management's decision to increase guidance, even...